This is a preview of subscription content, log in via an institution to check access.
Notes
2019 US dollars
Reference
Boettiger DC, et al. Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States. Journal of the International AIDS Society 24: No. 3, 21 Mar 2021. Available from: URL: https://doi.org/10.1002/jia2.25690
Rights and permissions
About this article
Cite this article
Pravastatin cost effective for preventing atherosclerotic CVD in people with HIV. PharmacoEcon Outcomes News 875, 24 (2021). https://doi.org/10.1007/s40274-021-7603-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7603-5